Puriblood Medical Co., Ltd. (6847.TWO)
TWD 86.9
(-12.4%)
TWD 86.9
(-12.4%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -65.84 Million TWD | -53.53% |
| 2022 | -42.88 Million TWD | 57.7% |
| 2021 | -101.39 Million TWD | -53.69% |
| 2020 | -65.97 Million TWD | -273.63% |
| 2019 | 37.99 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -48.91 Million TWD | 25.71% |
| 2024 Q2 | -69.3 Million TWD | 2.62% |
| 2023 Q4 | -65.84 Million TWD | 1.91% |
| 2023 FY | -65.84 Million TWD | -53.53% |
| 2023 Q3 | -67.12 Million TWD | -71.11% |
| 2023 Q1 | -40.48 Million TWD | 5.59% |
| 2023 Q2 | -39.22 Million TWD | 3.12% |
| 2022 Q3 | -44.13 Million TWD | 0.0% |
| 2022 FY | -42.88 Million TWD | 57.7% |
| 2022 Q4 | -42.88 Million TWD | 2.82% |
| 2021 FY | -101.39 Million TWD | -53.69% |
| 2020 FY | -65.97 Million TWD | -273.63% |
| 2019 FY | -1.66 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BIONET Corp. | -193.47 Million TWD | 65.97% |
| DIVA Laboratories, Ltd. | -534.39 Million TWD | 87.679% |
| Genetics Generation Advancement Corp. | -79.18 Million TWD | 16.85% |
| Welgene Biotech Co.,Ltd. | -33.78 Million TWD | -94.894% |
| TFBS Bioscience Inc. | -797.57 Million TWD | 91.745% |